ARWR
Arrowhead Pharmaceuticals, Inc.

Market cap $483.41M
Enterprise value $435.19M
Employees 93
Revenue $30.6M
EBITDA -$31.3M
Income -$35.5M
EPS -0.48
P/E N/A
Forward P/E -6.71
EV/EBITDA -13.92
PEG -0.99
Earnings date 2018-05-01
Volume 1.2M / 1.79M
Relative vol. 0.67 ×
Profit margin -116.17%
Oper. margin -117.53%
Gross margin 102.80%
Sales Q/Q -60.94%
Sales Y/Y 9,838.97%
Est. EPS Q/Q N/A
Beta 2.17
Mean Recomm. 2.40
IPO year 2000
Country United States
RSI 39.44
Range $5.46 – $5.95
52 weeks $1.42 – $6.75
SMA 50 $6 -0.40%
SMA 200 $4 -30.36%
1 year target $4 -22.80%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger